Global private equity and venture capital news and research

Posts Tagged ‘Novartis Venture Fund’

25 February 2014

Novo Ventures leads $49m Series B for anti-acne business Thesan Pharmaceuticals

skin5_lrg Biotechnology business Thesan Pharmaceuticals, which aims to treat skin disorders including acne and dermatitis, has picked up $49m of Series B financing led by existing backer Novo Ventures.

10 December 2013

Gimv leads €34m Series B investment in preclinical biotech developer Covagen

Belgium-based investment firm Gimv has led a €34m tranched Series B financing round for preclinical-stage biotech company Covagen, one of the largest private financing rounds of its kind.

29 April 2013

Venture firms queue up to back €33m Opsona Series C round

Opsona BB Biotech Ventures and Novartis Venture Fund have led a €33m Series C financing round for autoimmune system and inflammatory disease drug developer Opsona.

8 April 2013

GenSight Biologics raises €32.2m from four venture capital firms

Paris-based gene therapy specialist GenSight Biologics has raised €32.2m via a Series A round, which was co-led by Novartis Venture Fund, Abingworth, Versant Ventures and Index Ventures.

11 December 2012

Biotech developer Galera Therapeutics closes $11m Series A

Biotechnology company Galera Therapeutics has closed an $11m Series A venture capital financing co-led by New Enterprise Associates and Novartis Venture Fund, as well as Correlation Ventures.

10 December 2012

Astellas joins existing venture investors in £3.75m Bicycle Therapeutics deal

bicycle_sq Astellas Venture Management, the venture arm of Astellas Pharma, has backed a £3.75m financing round for UK business Bicycle Therapeutics.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014